Consensus on Essential Diagnostics for Advanced AIDS and fungal diseases

Experts from 27 countries have developed consensus on which diagnostic tests should be deemed ‘Essential’ by the World Health Organization. The WHO has had a listing of essential medicines for decades and has just launched a process for approving key tests for improved health and public health. This is the first time such a consensus meeting has been held.

Led by the Global Action Fund for Fungal Diseases (GAFFI), clinical practitioners from low and middle income countries debated the diagnostic performance, value for money and ease of use of 7 tests:

  • Cryptococcal antigen for cryptococcal meningitis in AIDS
  • Histoplasma antigen for disseminated histoplasmosis in AIDS
  • Toxoplasma antibody for brain abscess in AIDS and infection in pregnancy to avoid brain damaged newborns
  • Pneumocystis PCR for pneumonia in adults and children with AIDS
  • Aspergillus antibody to diagnose chronic pulmonary aspergillosis, often confused with tuberculosis
  • TB LAM an urine antigen test for rapid diagnosis of disseminated tuberculosis in AIDS that has been shown to save lives
  • Therapeutic antifungal drug monitoring for the life-saving, Essential Medicines itraconazole, voriconazole and flucytosine, to ensure adequate levels in the blood, often a problem in AIDS and children especially.

The meeting held in Kampala, Uganda on April 11, 2018.

The Medical Mycology Society of Nigeria President, Dr Rita Oladele was in attendance.

For more details see GAFFI site.

SIGHTS AT INVASIVE FUNGAL INFECTION FORUM, 2018

Participants at the recently concluded IFIF

Professor F Ogunsola, Deputy VC, UNILAG declaring the forum open.

Dr Uju Okaa, Faculty

 

Dr Rita Oladele, Co-ordinator and Dr Nick Irhurhe, Faculty

Presentation of Award to Pfizer Pharmaceuticals, IFIF sponsor

R-L: Dr Chioma Chidi, Dr Uju Okaa, Dr Rita Oladele, Dr Isi Aigbe and Dr.Osaigbovo